Trial Profile
A study to evaluate the IgE-mediated allergic reactions after the first administration of glatiramer acetate in patients with multiple sclerosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Glatiramer acetate (Primary) ; Mannitol
- Indications Multiple sclerosis
- Focus Adverse reactions
- 22 Dec 2015 New trial record